Arcellx (ACLX) Interest Expenses (2022 - 2025)
Arcellx's quarterly Interest Expenses came in at -$12000.0 in Q4 2025, down 271.43% year-on-year from $7000.0 in Q4 2024, and down 200.0% quarter-over-quarter from $12000.0 in Q1 2025.
Arcellx has reported Interest Expenses for 4 years, with the latest figure at -$12000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses fell 271.43% year-over-year to -$12000.0; the trailing twelve-month figure through Sep 2025 stood at $19000.0 (down 99.05% YoY), and the FY2024 full-year result was $1.0 million, down 73.19% from the prior year.
- Interest Expenses for Q4 2025 stood at -$12000.0, down from $12000.0 in the prior quarter.
- The five-year high for Interest Expenses was $1.1 million in Q4 2022, with the low at -$12000.0 in Q4 2025.
- Average Interest Expenses over 4 years is $470785.7, with a median of $454500.0 recorded in 2024.
- Year-over-year, Interest Expenses soared 29233.33% in 2023 and plunged 271.43% in 2025.
- Tracing ACLX's Interest Expenses over 4 years: stood at $1.1 million in 2022, then decreased by 12.46% to $977000.0 in 2023, then plunged by 99.28% to $7000.0 in 2024, then sank by 271.43% to -$12000.0 in 2025.
- The last three Interest Expenses figures came in at -$12000.0 (Q4 2025), $12000.0 (Q1 2025), and $7000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 321,000.00 |
| Jun 30, 2024 | 321,000.00 |
| Mar 31, 2024 | 588,000.00 |
| Mar 31, 2024 | 588,000.00 |
| Dec 31, 2023 | 977,000.00 |
| Dec 31, 2023 | 977,000.00 |
| Sep 30, 2023 | 959,000.00 |
| Sep 30, 2023 | 959,000.00 |
| Jun 30, 2023 | 880,000.00 |
| Jun 30, 2023 | 880,000.00 |
| Mar 31, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 596,000.00 |
| Sep 30, 2022 | 596,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |